Here is some other vaccine news of note for the week:
> About 37% of U.S. adults got a flu vaccine last year, according to the CDC. The figure represented about a 6% decline from the prior year. MarketWatch article
> CureVac started a phase 1 study of a mRNA-based rabies vaccine candidate. Release
> ImmusanT kicked off a phase 2 study of its Nexvax2 in patients with celiac disease. Release
> A report found that low vaccine confidence in Europe is contributing to a higher number of disease outbreaks. Reuters article
> Privately held biotech InvVax touted preclinical results for its universal flu vaccine candidate. Release